Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Avogaro

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Clinical Chemistry|June 1, 1979
Determination of high-density lipoproteins: screening methods comparedG M Kostner, P Avogaro, G B Bon, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|May 1, 1983
Familial study on "sinking pre-beta", the Lp(a) lipoprotein, and its relationship with serum lipids, apolipoprotein A-I and B and clinical atherosclerosisA Pagnan, G Kostner, M Braggion, et al.
Atherosclerosis|January 1, 1981
Lipoprotein Lp(a) and the risk for myocardial infarctionG M Kostner, P Avogaro, G Cazzolato, et al.
Giornale Di Clinica Medica|May 1, 1980
[Administration of simple carbohydrates (glucose) and compound carbohydrates (starches) in patients with renal insufficiency. Effects on glycemic and insulin responses]G Previato, C Lo Schiavo, N Tessitore, et al.
Pharmacological Research Communications|October 1, 1977
Modifications of lipids, lipoproteins and plasmatic apolipoproteins induced by a phospholipid extracted from calf heartP Avogaro, G Cazzolato, B G Bittolo, et al.
Experimental and Molecular Pathology|June 1, 1995
Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractionsV V Tertov, G Bittolo-Bon, I A Sobenin, et al.
European Journal of Clinical Investigation|June 1, 1978
Variations in apolipoproteins B and A1 during the course of myocardial infarctionP Avogaro, G B Bon, G Cazzolato, et al.
Journal of Lipid Research|April 1, 1994
Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-)H N Hodis, D M Kramsch, P Avogaro, et al.
Atherosclerosis|March 1, 1988
Plasma lipid lowering activity of acipimox in patients with type II and type IV hyperlipoproteinemia. Results of a multicenter trialG Crepaldi, P Avogaro, G C Descovich, et al.
Archives of Internal Medicine|January 1, 1991
Pravastatin vs gemfibrozil in the treatment of primary hypercholesterolemia. The Italian Multicenter Pravastatin Study IG Crepaldi, G Baggio, M Arca, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Clinical Chemistry|June 1, 1979
Determination of high-density lipoproteins: screening methods comparedG M Kostner, P Avogaro, G B Bon, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|May 1, 1983
Familial study on "sinking pre-beta", the Lp(a) lipoprotein, and its relationship with serum lipids, apolipoprotein A-I and B and clinical atherosclerosisA Pagnan, G Kostner, M Braggion, et al.
Atherosclerosis|January 1, 1981
Lipoprotein Lp(a) and the risk for myocardial infarctionG M Kostner, P Avogaro, G Cazzolato, et al.
Giornale Di Clinica Medica|May 1, 1980
[Administration of simple carbohydrates (glucose) and compound carbohydrates (starches) in patients with renal insufficiency. Effects on glycemic and insulin responses]G Previato, C Lo Schiavo, N Tessitore, et al.
Pharmacological Research Communications|October 1, 1977
Modifications of lipids, lipoproteins and plasmatic apolipoproteins induced by a phospholipid extracted from calf heartP Avogaro, G Cazzolato, B G Bittolo, et al.
Experimental and Molecular Pathology|June 1, 1995
Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractionsV V Tertov, G Bittolo-Bon, I A Sobenin, et al.
European Journal of Clinical Investigation|June 1, 1978
Variations in apolipoproteins B and A1 during the course of myocardial infarctionP Avogaro, G B Bon, G Cazzolato, et al.
Journal of Lipid Research|April 1, 1994
Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-)H N Hodis, D M Kramsch, P Avogaro, et al.
Atherosclerosis|March 1, 1988
Plasma lipid lowering activity of acipimox in patients with type II and type IV hyperlipoproteinemia. Results of a multicenter trialG Crepaldi, P Avogaro, G C Descovich, et al.
Archives of Internal Medicine|January 1, 1991
Pravastatin vs gemfibrozil in the treatment of primary hypercholesterolemia. The Italian Multicenter Pravastatin Study IG Crepaldi, G Baggio, M Arca, et al.
Pageof 9